- This article initiates coverage of Bayer Aktiengesellschaft often called Bayer AG or just Bayer.
- Bayer has significant short-term headwinds which have depressed the stock price.
- It has high levels of debt and continues to have litigation pressures that will likely cost more than €10 billion.
- However, Bayer is resilient having survived for over 150 years and appears well-positioned to benefit from several opportunities in the future.
- This article contains an introduction, a company summary, a qualitative SWOT analysis, a quantitative analysis, a valuation and a conclusion.
For further details see:
Bayer At Its Cheapest In A Decade